Trial
NCT03619187
An Interventional Study to Evaluate the Effect of Ivabradine on Exercise Capacity in Heart Transplant Recipients
Phase IIIWITHDRAWNOPERATIONALConfidence: HIGH
Sponsor
Amgen
Collaborators
—
Condition
Heart Transplantation, Elevated Resting Heart Rate
Intervention
Ivabradine
Why stopped
Sponsor decision
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2018-11-19